持久性左心室辅助装置支持下的左心室腔径纵向反应分析
研究前瞻性纳入32例连续接受Medtronic HeartWare心室辅助装置(HVAD)的患者,利用无创推导的压力-容积(PV)环在术后1、3、6个月评估心脏功能变化,并用混合效应模型分析人口学与装置变量对变化的影响。结果显示6个月内平均心室功能参数保持稳定,较低泵速、高搏动指数及缺血性心肌病指征与每搏功月度改善显著相关。
要点
- 32例HVAD患者术后6个月内平均心室功能参数保持稳定。
- 较低泵速(2400 rpm vs 2500-2800 rpm)预测每搏功月度改善。
- 高搏动指数(>1.0 vs <1.0)及缺血性心肌病指征与每搏功改善相关。
核心结论
- 无创PV环可确定LVAD支持下心室能量学与血流动力学改善的相关因素。
- 理解心室负荷增加以优化心肌重构的基础可能有助于筛选适合恢复的候选者。
研究设计与样本
- 前瞻性招募32例连续接受Medtronic HeartWare心室辅助装置(HVAD)的患者,平均年龄55.9±12.3岁,男性占81.3%。
- 使用经验证的算法估算单周期心室压力与容积,在预设术后时间点(1、3、6个月)获取PV环(n=77)及相应心腔动力学参数。
- 采用混合效应模型分析6个月内持续存在的PV环参数变化,并评估人口学与装置变量对观察变化的影响。
主要发现
- 6个月期间平均心室功能参数保持稳定。
- 较低泵速(2400 rpm vs 2500-2800 rpm)预测每搏功月度改善,效应量为0.0.051 mm Hg/liter/月(p=0.001)。
- 高搏动指数(>1.0 vs <1.0)预测每搏功月度改善,效应量为0.052 mm Hg/liter/月(p=0.012)。
- 缺血性心肌病作为LVAD植入指征(vs非缺血性)预测每搏功月度改善,效应量为0.0387 mm Hg/liter/月(p=0.007)。
- 心脏功率、峰值收缩压及左心室弹性等其他心腔功能参数在这些队列中也显示改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Left ventricular assist device (LVAD) support offers remodeling potential in some patients. Our goal was to use noninvasively derived pressure-volume (PV) loops to understand the effect of demographic and device variables on serial changes in cardiac function under pump support. METHODS: Thirty-two consecutive Medtronic HeartWare Ventricular Assist Device (HVAD) patients (mean 55.9 ± 12.3 years, 81.3% male) were prospectively recruited. Single-cycle ventricular pressure and volume were estimated using a validated algorithm. PV loops (n = 77) and corresponding cardiac chamber dynamics were derived at predefined postimplant timepoints (1, 3, 6 months). Changes in PV loop parameters sustained across the 6-month period were characterized using mixed-effects modeling. The influence of demographic and device variables on the observed changes was assessed. RESULTS: Across a 6-month period, the mean ventricular function parameters remained stable. Significant predictors of monthly improvement of stroke work include: lower pump speeds (2400 rpm vs 2500-2800 rpm) [0.0.051 mm Hg/liter/month (p = 0.001)], high pulsatility index (>1.0 vs <1.0) [0.052 mm Hg/liter/month (p = 0.012)], and ischemic cardiomyopathy indication for LVAD implantation (vs nonischemic) [0.0387 mm Hg/liter/month (p = 0.007)]. Various other cardiac chamber function parameters including cardiac power, peak systolic pressure, and LV elastance also showed improvements in these cohorts. CONCLUSIONS: Factors associated with improvement in ventricular energetics and hemodynamics under LVAD support can be determined with noninvasive PV loops. Understanding the basis of increasing ventricular load to optimize myocardial remodeling may prove valuable in selecting eligible recovery candidates.
引用
- Gunawan A, Robson D, Krishnaswamy RJ, et al. Longitudinal analysis left ventricular chamber responses under durable LVAD support. J Heart Lung Transplant. 2023. PMID: 37844674. doi:10.1016/j.healun.2023.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。